109 related articles for article (PubMed ID: 15133323)
21. Secondary resistance to cyclosporin A in children with nephrotic syndrome.
Sairam VK; Kalia A; Rajaraman S; Travis LB
Pediatr Nephrol; 2002 Oct; 17(10):842-6. PubMed ID: 12376814
[TBL] [Abstract][Full Text] [Related]
22. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
Cao Q; Huang WY; Xu H; Zhou LJ
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):698-701. PubMed ID: 19099862
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL
Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine therapy in steroid-dependent or steroid-resistant idiopathic focal and segmental glomerulosclerosis.
Gorsane I; Helal I; Yacoub I; Hamida FB; Abderrahim E; Abdallah TB
Saudi J Kidney Dis Transpl; 2016; 27(5):958-965. PubMed ID: 27752004
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine in the treatment of idiopathic focal segmental glomerulosclerosis.
Cattran DC
Semin Nephrol; 2003 Mar; 23(2):234-41. PubMed ID: 12704584
[TBL] [Abstract][Full Text] [Related]
26. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
[TBL] [Abstract][Full Text] [Related]
27. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
[TBL] [Abstract][Full Text] [Related]
28. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation.
Shishido S; Satou H; Muramatsu M; Hamasaki Y; Ishikura K; Hataya H; Honda M; Asanuma H; Aikawa A
Clin Transplant; 2013; 27(2):E143-50. PubMed ID: 23383697
[TBL] [Abstract][Full Text] [Related]
29. Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoring.
Ray JE; Keogh AM; McLachlan AJ
J Heart Lung Transplant; 2006 Oct; 25(10):1223-9. PubMed ID: 17045935
[TBL] [Abstract][Full Text] [Related]
30. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide.
Kershaw DB; Sedman AB; Kelsch RC; Bunchman TE
Clin Transplant; 1994 Dec; 8(6):546-9. PubMed ID: 7865917
[TBL] [Abstract][Full Text] [Related]
31. Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
Fujinaga S; Ohtomo Y; Someya T; Shimizu T; Yamashiro Y; Kaneko K
Clin Nephrol; 2008 Feb; 69(2):84-9. PubMed ID: 18218301
[TBL] [Abstract][Full Text] [Related]
32. A clinicopathologic study of primary focal segmental glomerulosclerosis in children.
Lanewala A; Mubarak M; Kazi JI; Akhter F; Sher A; Fayyaz A; Bhatti S
Saudi J Kidney Dis Transpl; 2012 May; 23(3):513-20. PubMed ID: 22569437
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
Segarra Medrano A; Vila Presas J; Pou Clavé L; Majó Masferrer J; Camps Doménech J
Nefrologia; 2011; 31(3):286-91. PubMed ID: 21468162
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of cyclophosphamide and cyclosporine in the treatment of steroid-resistant idiopathic nephrotic syndrome in children].
Rao J; Xu H; Cao Q; Huang WY; Zhou LJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):958-63. PubMed ID: 18182710
[TBL] [Abstract][Full Text] [Related]
35. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
36. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K; El-Reshaid W; Madda J
Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
[TBL] [Abstract][Full Text] [Related]
37. Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study.
Sheashaa H; Mahmoud I; El-Basuony F; El-Husseini A; Hassan N; El-Baz M; Ahmed NS; Sobh M
Int Urol Nephrol; 2007; 39(3):923-8. PubMed ID: 17447154
[TBL] [Abstract][Full Text] [Related]
38. [Long-term monitoring of children with focal segmental glomerulosclerosis and a transplanted kidney].
Seso Simić D; Slavicek J; Bubić Filipi L; Puretić Z; Kes P
Acta Med Croatica; 2003; 57(1):53-6. PubMed ID: 12876864
[TBL] [Abstract][Full Text] [Related]
39. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
Lieberman KV; Tejani A
J Am Soc Nephrol; 1996 Jan; 7(1):56-63. PubMed ID: 8808110
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
Chiou YY; Lee YC; Chen MJ
Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
